Using magnetic stimulation to improve motor symptoms in Parkinson's disease
Official title: A Randomized, Double-blind, Multicenter, Placebo-controlled Trial (PRESS-PD)
Run by Anhui Medical University · NCT06383247 · Data updated 2026-11-12
This study is testing if a new brain stimulation technique can help improve movement problems in people with Parkinson's disease.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 40 Years and up |
| Sex | All |
| Enrollment | 290 (estimated) |
| Sponsor | Anhui Medical University Academic / other |
| Locations | 1 site (Hefei, Anhui) |
| Status | Recruiting |
| Started | December 6, 2024 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2028 |
| Registry record updated | June 17, 2025 |
| Trial ID | NCT06383247 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals aged 40 and older diagnosed with idiopathic Parkinson's disease who meet specific clinical criteria.
✕Probably not a fit
Patients with secondary parkinsonism syndromes or those with severe brain injuries or implants that are incompatible with magnetic stimulation may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the efficacy and safety of repetitive transcranial magnetic stimulation (rTMS) in alleviating motor symptoms in patients with Parkinson's disease. It is a multi-center, double-blind, randomized controlled trial conducted across various hospital centers in China. The study focuses on stimulating the supplementary motor area of the brain using a specific stimulation protocol over a course of 7 days, with the aim of observing changes in clinical symptoms before and after the intervention.
Why it matters
Potential benefit: If successful, this treatment could significantly improve motor symptoms and potentially delay the progression of Parkinson's disease.
How similar studies have gone: Previous small sample studies have shown promising results for rTMS in treating Parkinson's disease, suggesting potential for success in this larger trial.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age ≥ 40 years old; 2. Meet the diagnostic criteria for idiopathic Parkinson's disease (MDS Diagnostic Criteria for Parkinson's Disease (2015 Edition))\[1\]; 3. Have no history of drug adjustment within 4 weeks before treatment and the entire study period; 4. The MDS-UPDRS Ⅲ score ≥8, and the Hoehn-Yahr rating is 1-4; 5. MMSE ≥22,able to cooperate with the completion of behavioral tests and transcranial magnetic stimulation therapy. Exclusion Criteria: 1. Previously head MRI/CT was focal brain injury or severe leukoencephalopathy (Fazekas grade 3 and above); 2. Various secondary parkinsonism syndromes (vascular parkinsonism, Parkinsonism combined with parkinsonism, drug parkinsonism, etc.); 3. Severe craniocerebral trauma, received craniocerebral surgery or deep brain stimulation treatment; 4. There are ferromagnetic implants in the body, such as cochlear implants, cardiac pacemakers, etc. 5. The person has a history of epilepsy, unexplained loss of consciousness, or are taking anticonvulsant drugs to treat epileptic seizures; 6. Diagnosed with a neuropsychiatric disorder other than PD 7. Have a history of drug abuse or drug use; 8. Participants in any clinical trial within the previous 6 month; 9. Pregnant/lactating women or subjects (including men) who have a birth plan within 6 months; 10. Other conditions deemed unsuitable for inclusion by the investigator.
Where it's running
-
Cognitive Neuropsychology Lab Anhui Medical University
Hefei, Anhui, China Recruiting
Study contacts
- Principal investigator: Panpan Hu, M.D. — The First Affiliated Hospital of Anhui Medical University
- Study coordinator: Panpan Hu, M.D.
- Email: hpppanda9@126.com
- Phone: +8613515602285
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
One-day exercise test to see how brain and body react in epilepsy, cognitive disorders, Parkinson's, dementia, and related conditions
A one-day study tests how an acute bout of exercise changes brain function and bodily signals in people with certain neurological conditions compared with healthy individuals.
-
Tributyrin for PSP: a virtual, early-phase study
This study tests whether tributyrin is safe and tolerable in people with Progressive Supranuclear Palsy who are 45 or older, using virtual visits.
-
A look at why Lewy body conditions cause visual hallucinations
This study tests brain‑imaging in people with Lewy body diseases who do or don’t experience visual hallucinations, and in healthy volunteers, to see how brain networks might create these images.
-
How physical activity might help people with Parkinson’s disease who have DBS-STN implants
This study tests whether adding regular physical activity can help people with Parkinson’s who have DBS-STN stimulation by trying a structured physiotherapy approach alongside standard care.
-
Can hippotherapy improve mobility, gait, balance, and quality of life in people with Parkinson's disease?
This pilot trial tests whether adding horse-assisted therapy to standard rehab helps mobility, gait, balance, and perceived health in adults with Parkinson's disease.
-
Gut methane and Parkinson's: measuring if a probiotic helps people with Parkinson's, REM sleep behavior disorder, or cognitive concerns
This study tests whether a probiotic containing Limosilactobacillus reuteri can help people with Parkinson's disease, those at high risk for PD, and related cognitive issues by potentially improving gut methane levels and overall symptoms.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.